Navigation Links
Specialists in drug discovery and development convene
Date:3/4/2008

More than 2,500 researchers and professionals in the area of biomolecular science and drug discovery are expected to attend the 14th Annual Conference & Exhibition of the Society for Biomolecular Sciences (SBS) April 6-10, in St. Louis at Americas Center to discuss advances in biotechnology, challenges and automation solutions in the field.

Highlights of topics and speakers at this years meeting include:

  • New Methods of Tracking Target Molecules -- Jeremy Caldwell, Ph.D., director of molecular and cell biology, Genomics Institute, Novartis Research Foundation, will conduct a panel discussion about the latest in drug therapies as used to target molecules associated with rare and orphan diseases. Through these new targets and applied technologies, therapies once thought to be impossible in major diseases may become available and will assist in the pursuit of therapies for the eradication of neglected diseases. Research to be presented includes RNA interference as a more effective way to help the body quickly respond to infectious and viral diseases.

  • New Trends in Pharmaceutical and Academic Collaborations -- A panel of National Institutes of Health and some of the worlds leading academic researchers will discuss the need for universities and non-profit institutes across the U.S. to increase their collaborative efforts with the pharmaceutical industry by applying their research findings to drug discovery for diseases pharmaceutical companies cant address on their own. As the pharmaceutical industry focuses on late stage drug development to get more effective medications to market, greater partnerships are necessary between academic and pharmaceutical researchers to discover more of the underlying causes for diseases. The panelists also are part of an increasing trend of more researchers segueing from the pharmaceutical industry to academic environments where there are fewer research constraints.

    '/>"/>

Contact: Jennifer Bender
jbender@environics-usa.com
203-325-8772 x18
Society for Biomolecular Sciences
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Jefferson specialists studying innovative surgery for effectively treating sleep apnea
2. RESolutions Rapid Enrollment Solutions, LLC Mobilizes Team of Regional Recruitment Specialists(TM)
3. The Cardiovascular Multimedia Network (CVMD) and the International Society of Endovascular Specialists (ISES) Join Forces to Educate Practitioners Worldwide Through Electronic Media
4. IPS Secures National Contract to Deliver FOCUS Healthcare Provider Network Access to Pain Management Specialists
5. Training Medical Warriors: Tropical Medicine Specialists Who Ward Off Bioterrorist and Global Health Threats Pass the Torch to the Next Generation
6. Northern Fertility & Reproductive Associates Adds Two Local Infertility Specialists to Staff, Opens New Offices In Center City And Blue Bell
7. Georgia Cancer Specialists to Sponsor Sixth Annual Totes 2 Tots Suitcase Drive for Foster Children
8. Discovery of sugar sensor in intestine could benefit diabetes
9. Discovery suggests location of genes for breast density, a strong risk factor for breast cancer
10. Stem cell research produces a key discovery for Fragile X Syndrome
11. Welch Foundation gives $1.6 million for drug discovery research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... Amy Norton HealthDay ... Yoga has long been believed to improve overall health, but ... also help the heart, a new review finds. In ... such as brisk walking, said lead researcher Paula Chu, a ... The review, of 37 clinical trials, found that people ...
(Date:12/15/2014)... NV (PRWEB) December 15, 2014 Veretekk.com, ... company, JM Ocean Avenue. JM Ocean Avenue has ... the Veretekk online automated marketing system. JM Ocean ... June 2014 merger of Ocean Avenue and JM International, ... than $2 Billion per year company. , “After nearly ...
(Date:12/15/2014)... 2014 OutMarket , a provider ... Social Media Cheat Sheets ,” a guide that exposes ... results on the top ten social media networks. ... drive awareness, engagement, and customer service. It can also ... an impact on new networks and weather constantly changing ...
(Date:12/15/2014)... The increase in prevalence of disabling hearing ... factors which is contributing to the growth in the global ... treatment of hearing loss and balance disorders are known as ... microphone, speaker and amplifier. The global market is expected to ... the period from 2014 to 2019. Some of the factors ...
(Date:12/15/2014)... 15, 2014 At the leading, long-established ... AutismOne and Focus Autism will welcome ... research on the effects of toxins to children’s health, ... information. , Luminaries such as Dr. Lucija Tomljenovic ... with esteemed, credentialed colleagues of the United States to ...
Breaking Medicine News(10 mins):Health News:Yoga May Cut Heart Disease Risk Factors 2Health News:Yoga May Cut Heart Disease Risk Factors 3Health News:JM Ocean Avenue secures the strategic advantages of Veretekk 2Health News:JM Ocean Avenue secures the strategic advantages of Veretekk 3Health News:JM Ocean Avenue secures the strategic advantages of Veretekk 4Health News:OutMarket Releases Cheat Sheets for Social Media Marketing 2Health News:OutMarket Releases Cheat Sheets for Social Media Marketing 3Health News:Audiological Devices Market 2019 Demand for Esthetic Hearing Aids Drives the Growth, Says a Report at ReportsnReports.com 2Health News:Audiological Devices Market 2019 Demand for Esthetic Hearing Aids Drives the Growth, Says a Report at ReportsnReports.com 3Health News:Audiological Devices Market 2019 Demand for Esthetic Hearing Aids Drives the Growth, Says a Report at ReportsnReports.com 4Health News:AutismOne and Focus Autism Collaborate on Scientific Conference; International Group of Researchers to Present in Chicago, May 2015 2Health News:AutismOne and Focus Autism Collaborate on Scientific Conference; International Group of Researchers to Present in Chicago, May 2015 3
... in China has revealed that just over 67 per cent ... ,This survey was conducted recently by a research institute at ... respondents in 24 colleges of 19 cities.,The results said that ... how HIV/AIDS is transmitted and 75.6 per cent know how ...
... drugs (NSAIDs) or COX-2-selective NSAIDs, have reduced risk ... // These results were from from two clinical ... edition of the American Journal of Gastroenterology. ... naproxen and aspirin, and newer COX-2-selective agents. ...
... Chief Minister of Bihar Mr. Nitish Kumar is all for ... Devi used to cultivate potato, tomato and green vegetables// at ... a resource centre for herbal farming. ,Nitish Kumar ... father was a leading ayurvedic practitioner in his home district ...
... and cinnamon odors can increase alertness and decrease fatigue ... conducted this interesting study under the able guidance of ... ,Results of the study revealed that both cinnamon ... course of driving. Cinnamon proved to better than it’s ...
... the World Health Organization (WHO), there is an outbreak of ... home-preserved// bamboo shoots. It has left more than 150 ... that according to the Thai Ministry of Public Health (MOPH) ... as on March 20th. About a 100 people are hospitalized ...
... recent study conducted among 8,000 men aged 16 to 59, it ... cigarettes a day are almost 40 %// more likely to be ... a month or more in the previous year. Those who smoked ... to report impotence problems. Anti-smoking campaigners welcome this kind of research ...
Cached Medicine News:Health News:Patients on NSAIDS have reduced gastric ulcers risk by Nexium? 2Health News:Bamboo Shoots Causes Botulism Outbreak 2Health News:Smoking Is a Vital Cause among Impotent Men 2
(Date:12/15/2014)... Investor-Edge has initiated coverage on the following equities: ... Company (NYSE: LLY ), Nektar Therapeutics (NASDAQ: ... Novartis AG (NYSE: NVS ). Free research on ... . On Friday, December 12, 2014, the NASDAQ Composite ... lost 1.79%, to finish the day at 17,280.83, and the ...
(Date:12/15/2014)... Dec. 15, 2014  The Government of Ghana ... Global Blood Fund (GBF) and Terumo BCT to respond to the ... well as provide long-term health system capacity to the citizens of ... , The Ghanaian Ebola Readiness and Resilience Initiative (GERRI) is a ... preparations for the possible arrival of the Ebola epidemic ...
(Date:12/13/2014)... Research and Markets ( ... the  "Global Catheters Market (Product Types and ... Profiles, Analysis, Segmentation and Forecast, 2013 - ...      (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , , ,Catheters ... grade material such as plastic, silicon rubber, ...
Breaking Medicine Technology:Analysts View on Pharma Equities - Zogenix, Eli Lilly, Nektar Therapeutics, Sanofi, and Novartis 2Analysts View on Pharma Equities - Zogenix, Eli Lilly, Nektar Therapeutics, Sanofi, and Novartis 3Analysts View on Pharma Equities - Zogenix, Eli Lilly, Nektar Therapeutics, Sanofi, and Novartis 4Analysts View on Pharma Equities - Zogenix, Eli Lilly, Nektar Therapeutics, Sanofi, and Novartis 5Government of Ghana Endorses Collaboration to Combat Ebola Epidemic 2Government of Ghana Endorses Collaboration to Combat Ebola Epidemic 3Government of Ghana Endorses Collaboration to Combat Ebola Epidemic 4Government of Ghana Endorses Collaboration to Combat Ebola Epidemic 5Government of Ghana Endorses Collaboration to Combat Ebola Epidemic 6Global Catheters Market (Product Types and Geography) - Forecast to 2020 2Global Catheters Market (Product Types and Geography) - Forecast to 2020 3
... Data Shows Long-term Improvements in Productivity, Quality of ... American College ... Oct. 27 5:00 AM PST -- UCB announced,today ... pegol) - the only PEGylated anti-TNF (Tumor Necrosis Factor),- ...
... SOUTH SAN FRANCISCO, Calif., Oct. 26 Monogram,Biosciences, ... data presented this,week demonstrated that in Pfizer Inc,s ... (maraviroc) in treatment naive individuals with CCR5-tropic,HIV-1, increased ... enrichment of the,patient population by use of the ...
Cached Medicine Technology:CIMZIA(R) (Certolizumab Pegol) Provides Rapid and Sustained Relief from Signs and Symptoms of Rheumatoid Arthritis for Two Years 2CIMZIA(R) (Certolizumab Pegol) Provides Rapid and Sustained Relief from Signs and Symptoms of Rheumatoid Arthritis for Two Years 3CIMZIA(R) (Certolizumab Pegol) Provides Rapid and Sustained Relief from Signs and Symptoms of Rheumatoid Arthritis for Two Years 4CIMZIA(R) (Certolizumab Pegol) Provides Rapid and Sustained Relief from Signs and Symptoms of Rheumatoid Arthritis for Two Years 5CIMZIA(R) (Certolizumab Pegol) Provides Rapid and Sustained Relief from Signs and Symptoms of Rheumatoid Arthritis for Two Years 6CIMZIA(R) (Certolizumab Pegol) Provides Rapid and Sustained Relief from Signs and Symptoms of Rheumatoid Arthritis for Two Years 7CIMZIA(R) (Certolizumab Pegol) Provides Rapid and Sustained Relief from Signs and Symptoms of Rheumatoid Arthritis for Two Years 8CIMZIA(R) (Certolizumab Pegol) Provides Rapid and Sustained Relief from Signs and Symptoms of Rheumatoid Arthritis for Two Years 9CIMZIA(R) (Certolizumab Pegol) Provides Rapid and Sustained Relief from Signs and Symptoms of Rheumatoid Arthritis for Two Years 10Data Reported at ICAAC Indicates Selzentry(TM) Phase III Treatment-Naive Trial Shows Increased Efficacy When Used With Enhanced Trofile(TM) Assay 2Data Reported at ICAAC Indicates Selzentry(TM) Phase III Treatment-Naive Trial Shows Increased Efficacy When Used With Enhanced Trofile(TM) Assay 3Data Reported at ICAAC Indicates Selzentry(TM) Phase III Treatment-Naive Trial Shows Increased Efficacy When Used With Enhanced Trofile(TM) Assay 4Data Reported at ICAAC Indicates Selzentry(TM) Phase III Treatment-Naive Trial Shows Increased Efficacy When Used With Enhanced Trofile(TM) Assay 5Data Reported at ICAAC Indicates Selzentry(TM) Phase III Treatment-Naive Trial Shows Increased Efficacy When Used With Enhanced Trofile(TM) Assay 6
This compression garment can be used immediatlely following Abdominoplasty, Tram Flap, Abdominal Liposuction, Lipoplasty, Suction Lipectomy, Stomach Liposuction, Liposculpture and Tummy Tuck procedur...
Black Spandex Above the Knee Compression Girdles with Contact Closure with Zipper...
Bodyshaper For Men...
Ideal for abdominal, hip, thigh and knee procedures....
Medicine Products: